CAV2 and familial pancreatic carcinoma: Thus, unravelling the role of CAV2 and MiR-4723 in pancreatic cancer and further exploring their mechanisms can facilitate the expansion of the knowledge about the molecular mechanisms of pancreatic cancer development to lay a theoretical foundation for the further exploration of early diagnosis, clinical behaviour prediction, immunotherapy, or targeted biological therapy for pancreatic cancer treatment.